When people go bald, hair follicles (the tube-like pores that surround the root and strand of a hair) don’t disappear, they ...

University of Oslo scientists identified a panel of four microRNAs that can distinguish between heart failure types and ...

Alzheimer’s disease (AD) accounts for 60–80% of all dementia cases, with women at higher risk due to both longevity and biological factors. Familial AD, ...

Aspira Executes New, Scalable Laboratory Services Agreement in One of the Largest Markets in the US AUSTIN, TX AND WASHINGTON, DC / ACCESS Newswire / October 29, 2025 / Aspira Women's Health Inc., ...

One of the most frightening things about Alzheimer's disease is how difficult it is to diagnose early. Now, University of ...

Causeway Therapeutics, a clinical-stage biotechnology company developing novel medicines for tendon disease, today announced positive topline data from its Phase 2 clinical trial evaluating TenoMiR ® ...

Causeway Therapeutics, a clinical-stage biotechnology company developing novel medicines for tendon disease, today announced positive topline data from its Phase 2 clinical ...

Researchers uncover that ALV-J boosts miR-155 to suppress TRAF3 and STAT1, weakening immune responses and promoting viral ...

Gorakhpur: Basti-born woman scientist Priyanshu Srivastava has carved an inspiring path from a small UP town to cutting-edge ...

Bananas rank among the world's most valuable staple crops, yet their production faces severe losses from Fusarium wilt caused ...

A phase 2 study supports the use of a microRNA eye drop for patients with corneal damage or dry eye disease.

In 2015, Bluestone led a small clinical trial to isolate and grow Tregs from diabetes patients and then reinfuse the cells ...